Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Benzel

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Molecules (Basel, Switzerland)|March 3, 2021
Rapid MALDI-MS Assays for Drug Quantification in Biological Matrices: Lessons Learned, New Developments, and Future PerspectivesMargaux Fresnais, Esra Yildirim, Seda Karabulut, et al.
Pharmaceutics|September 28, 2021
Investigating the Central Nervous System Disposition of Actinomycin D: Implementation and Evaluation of Cerebral Microdialysis and Brain Tissue Measurements Supported by UPLC-MS/MS QuantificationJulia Benzel, Gzona Bajraktari-Sylejmani, Philipp Uhl, et al.
Journal of the American Society for Mass Spectrometry|January 24, 2020
Rapid and Sensitive Drug Quantification in Tissue Sections Using Matrix Assisted Laser Desorption Ionization-Ion Mobility-Mass Spectrometry ProfilingMargaux Fresnais, Alexander Muck, Marius Majewsky, et al.
Clinical Pharmacology and Therapeutics|July 13, 2023
Key Pharmacokinetic Parameters of 74 Pediatric Anticancer Drugs Providing Assistance in Preclinical StudiesNora Jamaladdin, Romain Sigaud, Daniela Kocher, et al.
Pharmaceuticals (Basel, Switzerland)|June 24, 2022
Analytical Performance Evaluation of New DESI Enhancements for Targeted Drug Quantification in Tissue SectionsMargaux Fresnais, Siwen Liang, Marius Breitkopf, et al.
Cellular and Molecular Life Sciences : CMLS|June 19, 2019
Degradome of soluble ADAM10 and ADAM17 metalloproteasesFranka Scharfenberg, Andreas Helbig, Martin Sammel, et al.
Scientific Reports|April 10, 2026
Ependymoma group-specific blood-brain barrier differences uncovered by a multi-omics approachJulia K Sundheimer, Julia Benzel, Aniello Federico, et al.
Neuro-Oncology|July 26, 2022
The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma modelsRomain Sigaud, Lisa Rösch, Charlotte Gatzweiler, et al.
Acta Neuropathologica|August 16, 2019
MYCN amplification drives an aggressive form of spinal ependymomaDavid R Ghasemi, Martin Sill, Konstantin Okonechnikov, et al.
Cancer Discovery|April 21, 2021
Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial EpendymomasTuyu Zheng, David R Ghasemi, Konstantin Okonechnikov, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Molecules (Basel, Switzerland)|March 3, 2021
Rapid MALDI-MS Assays for Drug Quantification in Biological Matrices: Lessons Learned, New Developments, and Future PerspectivesMargaux Fresnais, Esra Yildirim, Seda Karabulut, et al.
Pharmaceutics|September 28, 2021
Investigating the Central Nervous System Disposition of Actinomycin D: Implementation and Evaluation of Cerebral Microdialysis and Brain Tissue Measurements Supported by UPLC-MS/MS QuantificationJulia Benzel, Gzona Bajraktari-Sylejmani, Philipp Uhl, et al.
Journal of the American Society for Mass Spectrometry|January 24, 2020
Rapid and Sensitive Drug Quantification in Tissue Sections Using Matrix Assisted Laser Desorption Ionization-Ion Mobility-Mass Spectrometry ProfilingMargaux Fresnais, Alexander Muck, Marius Majewsky, et al.
Clinical Pharmacology and Therapeutics|July 13, 2023
Key Pharmacokinetic Parameters of 74 Pediatric Anticancer Drugs Providing Assistance in Preclinical StudiesNora Jamaladdin, Romain Sigaud, Daniela Kocher, et al.
Pharmaceuticals (Basel, Switzerland)|June 24, 2022
Analytical Performance Evaluation of New DESI Enhancements for Targeted Drug Quantification in Tissue SectionsMargaux Fresnais, Siwen Liang, Marius Breitkopf, et al.
Cellular and Molecular Life Sciences : CMLS|June 19, 2019
Degradome of soluble ADAM10 and ADAM17 metalloproteasesFranka Scharfenberg, Andreas Helbig, Martin Sammel, et al.
Scientific Reports|April 10, 2026
Ependymoma group-specific blood-brain barrier differences uncovered by a multi-omics approachJulia K Sundheimer, Julia Benzel, Aniello Federico, et al.
Neuro-Oncology|July 26, 2022
The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma modelsRomain Sigaud, Lisa Rösch, Charlotte Gatzweiler, et al.
Acta Neuropathologica|August 16, 2019
MYCN amplification drives an aggressive form of spinal ependymomaDavid R Ghasemi, Martin Sill, Konstantin Okonechnikov, et al.
Cancer Discovery|April 21, 2021
Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial EpendymomasTuyu Zheng, David R Ghasemi, Konstantin Okonechnikov, et al.
Pageof 3